Otitis Media

Otitis media is a disease of the middle ear that involves an inflammation of the ear’s lining. Many parents are familiar with otitis media, as the condition is frequently diagnosed in childhood (an ear infection). It can occur acutely or develop into a chronic condition, and there are many different bacteria associated with otitis media. When children have repeated episodes of otitis media, doctors will often recommend implantation of tympanostomy tubes — cylinders that are surgically inserted into the eardrum to provide ventilation and prevent buildup of fluids. Biofilms — conglomerations of microorganisms that are a major cause of infections — have been shown to occur in the inner surface of tympanostomy tubes. Researchers have observed biofilm formation on every tympanostomy tube inserted into the ear of guinea pigs. To put it bluntly, tympanostomy tubes are overused. Doctors are much too quick to recommend surgical implantation of a tube instead of searching for the underlyin

As Biotechnology businesses, AC Immune SA (NASDAQ:ACIU) and Novus Therapeutics Inc. (NASDAQ:NVUS), are affected by compare. This especially applies to their risk, analyst recommendations, profitability, institutional ownership, dividends, earnings and valuation. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio AC Immune SA N/A 0.00 N/A -0.54 0.00 Novus Therapeutics Inc. N/A 0.00 11.60M -1.37 0.00 We can see in table 1 the earnings per share (EPS), gross revenue and valuation of AC Immune SA and Novus Therapeutics Inc. Profitability Table 2 provides the return on assets, net margins and return on equity of the two firms. Net Margins Return on Equity Return on Assets AC Immune SA 0.00% -25.2% -22.4% Novus Therapeutics Inc. 0.00% -55.5% -51.7% Liquidity 19.2 and 19.2 are the respective Current Ratio and a Quick Ratio of AC Immune SA. Its rival Novus Therapeutics Inc.’s Cu

LONDON--( BUSINESS WIRE )--The global ear infection treatment market is expected to post a CAGR of over 5% during the period 2019-2023, according to the latest market research report by Technavio . Depending on the part of the ear infected, it is classified as acute otitis externa (AOE), otitis media with effusion (OME), and acute otitis media (AOM). These infections are caused due to various risk factors such as bacteria, viral cold or flu season, injury to the ear, and cigarette smoke. Exposure to cigarette smoke can result in an increased occurrence of AOM. Such high-risk factors significantly increase the chances of ear infections, driving the global ear infection treatment market during the forecast period. As per Technavio, raising funds for research on ear infections will have a positive impact on the market and contribute to its growth significantly over the forecast period. This global ear infection treatment market 2019-2023 research report also analyzes other important t

It is important to know how long do ear infections last, especially when you develop one yourself. Knowing how your body reacts to a certain disease and how long it takes for it to recover can give you the necessary confidence to keep pushing forward. There is no room for fear once you are fighting to get better. Sometimes the only thing you can and should do is be patient, trust your treatment, and endure the time that it takes for you to finally prevail. In this article, you will find out exactly how long do ear infections last and how they are usually treated. Ear Infections: Valuable Info If you hear the term “otitis media”, don’t let it frighten you as that is just another name for an ear infection. Ear infection is a very common disease among children. According to research , this condition mostly targets children between 6 months and 3 years of age. However, that doesn’t mean that adults are safe. It just means that adults are, well, safer. You see, we are able to hear be

CLARK COUNTY, Wa. — As of Thursday, lab results on 24 children and one adult from Clark County, Washington, were confirmed for measles. Most of those who contracted the highly contagious disease were unvaccinated according to a news release from Health District 3, Southwest District Health. To date, no measles cases have been reported in Idaho or Oregon as a result of this outbreak. Health-care providers should consider measles in patients presenting with febrile rash illness and clinically compatible symptoms, especially if the patient recently travelled internationally or to locales in the United States experiencing a measles outbreak, including Clark County, Washington and Portland, Oregon. Measles is a viral respiratory illness that is vaccine-preventable. According to the news release, it is characterized by a prodrome of fever (as high as 105 degrees Fahrenheit), malaise, the “three C’s” (cough, coryza, and conjunctivitis), and Koplik spots followed (two to four days later

The worldwide market for Acute Otitis Media Treatment is expected to grow at a CAGR of roughly 5.1% over the next five years, will reach 2750 million US$ in 2023, from 2040 million US$ in 2017, according to a new research study. Market Segment by Type, covers: Antibiotics Nonsteroidal anti-Inflammatory drug Analgesic Anaesthetic Market Segment by Applications, can be divided into: Hospitals Retail pharmacies Online pharmacies Browse Full Report at https://www.industryresearch.co/13679989 Subsequent 15 Chapters to profoundly shows the global Acute Otitis Media Treatment market 2019: Chapter 1: Acute Otitis Media Treatment Introduction, product scope, market overview, market opportunities, market risk, market driving force Chapter 2: Top manufacturers of Acute Otitis Media Treatment, with sales, revenue, and price of Acute Otitis Media Treatment, in 2017 and 2018 Chapter 3: Competitive situation among the top manufacturers, with sales, revenue and market share in 2017 an

The worldwide market for Acute Otitis Media Treatment is expected to grow at a CAGR of roughly 5.1% over the next five years, will reach 2750 million US$ in 2023, from 2040 million US$ in 2017, according to a new research study. Market Segment by Type, covers: Antibiotics Nonsteroidal anti-Inflammatory drug Analgesic Anaesthetic Market Segment by Applications, can be divided into: Hospitals Retail pharmacies Online pharmacies Browse Full Report at https://www.industryresearch.co/13679989 Subsequent 15 Chapters to profoundly shows the global Acute Otitis Media Treatment market 2019: Chapter 1: Acute Otitis Media Treatment Introduction, product scope, market overview, market opportunities, market risk, market driving force Chapter 2: Top manufacturers of Acute Otitis Media Treatment, with sales, revenue, and price of Acute Otitis Media Treatment, in 2017 and 2018 Chapter 3: Competitive situation among the top manufacturers, with sales, revenue and market share in 2017 an

The worldwide market for Acute Otitis Media Treatment is expected to grow at a CAGR of roughly 5.1% over the next five years, will reach 2750 million US$ in 2023, from 2040 million US$ in 2017, according to a new research study. Market Segment by Type, covers: Antibiotics Nonsteroidal anti-Inflammatory drug Analgesic Anaesthetic Market Segment by Applications, can be divided into: Hospitals Retail pharmacies Online pharmacies Browse Full Report at https://www.industryresearch.co/13679989 Subsequent 15 Chapters to profoundly shows the global Acute Otitis Media Treatment market 2019: Chapter 1: Acute Otitis Media Treatment Introduction, product scope, market overview, market opportunities, market risk, market driving force Chapter 2: Top manufacturers of Acute Otitis Media Treatment, with sales, revenue, and price of Acute Otitis Media Treatment, in 2017 and 2018 Chapter 3: Competitive situation among the top manufacturers, with sales, revenue and market share in 2017 an

Brett Burstein A quarter of children aged younger than 2 years with bronchiolitis who visited U.S. EDs between 2007 and 2015 received antibiotics, even though 70% of those patients had no bacterial coinfection, according to study results published in the Journal of Pediatric Infectious Diseases Society . “Bronchiolitis is a viral infection that does not respond to or require antibiotic treatment, and guidelines of the AAP, first published in 2006 and reiterated in 2014 , recommend against the use of antibiotics for this illness,” Brett Burstein, MD, Ph D , MPH, FRCPC, FAAP, told Infectious Diseases in Children . “Also, since 2013, reducing antibiotic prescribing for viral respiratory illness, including bronchiolitis, has become the top priority of the AAP’s Choosing Wisely national campaign. Despite these recommendations, we found that rates of antibiotic use did not decrease significantly in the decade following the guidelines.” Burstein, who is an assistant professor of emergen

2019 Latest Report Titled on: “ Otitis Media – Epidemiology Forecast to 2028 “ Otitis Media   Market  – Report provides a complete understanding of the pipeline activities covering all  clinical, pre-clinical and discovery stage products . It provides pipeline product profiles which include product  description, developmental activities, licensors & collaborators and chemical information.  The report provides comprehensive insights of the ongoing therapeutic research and development. Methodology of Otitis Media   Market : The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by team of industry experts. Secondary information and data has been collected from various printable and non-printable sources like search engines, news websites, government websites, trade journals, white papers, magazines, trade associations, books, industry portals, industry associations and available databases. Scop

This press release was orginally distributed by SBWire Albany, NY -- ( SBWIRE ) -- 01/21/2019 -- Surged incidences of hearing ailments such as otic disorders triggered by accumulation of excessive ear wax amongst children are likely to enhance growth in tympanostomy products market. Technological sophistication favoring novel tympanostomy tubes are likely to foster growth in global tympanostomy products market. Additionally, spike in healthcare expenditure is also likely to favor growth in forthcoming years. These market highlights are in accordance with a recent research offering titled, ' Tympanostomy Products Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026' included in the database of Market Research Hub. Budding Start-Up PoinEar Disrupts Tympanostomy Products Market with Sleeker Tubes Leading players in tympanostomy products market are engaged in offering distinctive offerings to diversify the portfolio. Further, leading players

Marieke L.A. de Hoog , PhD ⇑ 1 , Roderick P. Venekamp , MD, PhD 1 , Roger A.M.J. Damoiseaux , MD, PhD 1 , Anne G.M. Schilder , MD, PhD 1 , 2 , Elisabeth A.M. Sanders , MD, PhD 3 , 4 , Henriette A. Smit , PhD 1 and Patricia C.J.L. Bruijning-Verhagen , MD, PhD 1 , 4 1 Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht University, The Netherlands 2 evidENT, Ear Institute, University College London, London, United Kingdom 3 Wilhelmina Children’s Hospital, University Medical Center, Utrecht University, The Netherlands 4 Netherlands National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands CORRESPONDING AUTHOR: Marieke L.A. de Hoog, PhD, Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht STR 6.131, PO Box 85500, 3508 GA Utrecht, The Netherlands. m.l.a.dehoog{at}umcutrecht.nl Abstract PURPOSE Annual influenza immunization in medical risk groups is recomme

Upper respiratory infections, or URIs, are more common among children who develop acute sinusitis, according to research published in Clinical Infectious Diseases . Although respiratory syncytial virus was the most common cause of URI among children with sinusitis, 30% of patients with the condition had a new viral pathogen present in samples collected on the 10th day of symptoms, researchers said. The findings suggest that some children thought to have sinusitis are instead experiencing sequential viral infections, according to Gregory P. DeMuri, MD, professor of pediatric infectious diseases at the University of Wisconsin School of Medicine and Public Health, and colleagues. The researchers wrote that viral upper respiratory infections may cause inflammation of mucosal membranes in the nose and nasopharynx. This can cause the sinus ostia to become obstructed and allow bacteria to grow in the nasopharynx and cause complications like acute sinusitis and acute otitis media , accordi

This press release was orginally distributed by SBWire Albany, NY -- ( SBWIRE ) -- 01/21/2019 -- Surged incidences of hearing ailments such as otic disorders triggered by accumulation of excessive ear wax amongst children are likely to enhance growth in tympanostomy products market. Technological sophistication favoring novel tympanostomy tubes are likely to foster growth in global tympanostomy products market. Additionally, spike in healthcare expenditure is also likely to favor growth in forthcoming years. These market highlights are in accordance with a recent research offering titled, ' Tympanostomy Products Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026' included in the database of Market Research Hub. Budding Start-Up PoinEar Disrupts Tympanostomy Products Market with Sleeker Tubes Leading players in tympanostomy products market are engaged in offering distinctive offerings to diversify the portfolio. Further, leading players

THURSDAY, Jan. 17, 2019 (HealthDay News) — Most children younger than 2 years with bronchiolitis seen in U.S. emergency departments and prescribed antibiotics have no documented bacterial coinfection, according to a study published online Jan. 17 in the Journal of the Pediatric Infectious Diseases Society . Jesse Papenburg, M.D., from McGill University in Montreal, and colleagues conducted a repeated cross-sectional analysis of emergency department data from the National Hospital Ambulatory Medical Care Survey from 2007 to 2015. The study population included all children aged <2 years with a discharge diagnosis of bronchiolitis. The researchers identified 59,921 unweighted emergency department visits by pediatric patients during 2007 to 2015; of these, 1.1 percent met the inclusion criteria, representing an estimated 2.92 million emergency department visits for bronchiolitis in children aged <2 years. Overall, 89.7 percent of all visits were emergency department discharges. In